Professor Gerald Holtmann
During the last 30 years, Professor Holtmann has been very fortunate to be able to drive a paradigm shift for the pathophysiologic concepts of functional gastrointestinal disorders. While initially considered a ‘psychosomatic disorder’, his work identified genetic risk factors (e.g. the GNB3 polymorphism) and established a now widely accepted concept of minimal systemic inflammation as […]
Professor Christopher Del Mar (Vale)
I am an academic general practitioner, currently Professor of Public Health. Formerly Pro-Vice Chancellor (Research), and simultaneously Dean of Health Sciences and Medicine at Bond University – where I successfully started the first private Australian university medical program – I was previously Professor of General Practice at the University of Queensland. A well-known evidence-based practice expert, I have […]
Professor David Theile
Professor Pamela Russell (Vale)
Highly creative scientist, Professor Pam Russell, initiated cyclophosphamide therapy for autoimmunity and is internationally recognized for generating urological cancer models for study. She directed the Oncology Research Centre, Prince of Wales Hospital, Sydney for 17 years, published 200 papers, patents, procured $34m in grants and mentored postgraduates and 30 postdoctoral fellows. Discoveries include antibodies to […]
Professor Peter Sly
Professor Peter Sly is an acknowledged pioneer in understanding the early origins of lung disease and the implications for lung health in the long term. He has discovered major risk factors for the development of asthma and for the onset of cystic fibrosis lung disease, leading to a number of testable hypotheses to prevent or […]
Professor Ranjeny Thomas
Professor Ranjeny Thomas is an NHMRC Research Fellow recognized as an international leader in the field of antigen-specific tolerance in rheumatoid arthritis (RA). During the last 5 years, she reported the first clinical trial of antigen-specific dendritic cell therapy in RA, and attracted investment from the US-based Johnson and Johnson group of companies into Dendright, […]